Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN110511214A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110511214A reveals a ruthenium-catalyzed route for diamine heterocycles, offering cost reduction and scalable supply for antitumor pharmaceutical intermediates.